Norstella Executive and Leadership Team

July, 2026

Leadership Overview

Norstella has 6 executives leading key functions including strategy, finance, revenue, technology, and evidence generation.

Driven by a shared goal of improving patient access, Norstella unites market-leading companies to deliver critical answers for strategic and commercial decision-making, navigating complexities from pipeline to patient.

Leadership Roles at Norstella

  • Chief Executive Officer - Michael Gallup
  • Chief Financial Officer - Daniel Tempesta
  • Chief Revenue Officer - Elizabeth Addlesberger
  • Chief Technology Officer - Andrew Augustine
  • Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation - Joel Keefe
  • Chief Revenue Officer, Heorand Rwe & Rwd & Skipta - Kevin D'Ambrosia
  • Michael Gallup - Chief Executive Officer

    Michael Gallup, the Chief Executive Officer at Norstella, directs the overarching strategy and vision for the organization. Gallup guides Norstella's mission to improve patient access by uniting its market-leading companies. This leadership involves ensuring each entity, including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group, effectively delivers essential answers for critical strategic and commercial decision-making. Gallup's focus is on leveraging the combined expertise, cutting-edge data solutions, and advanced technologies like real-world data, machine learning, and predictive analytics to support life sciences clients. The Chief Executive Officer ensures Norstella navigates the complexities of the drug development life cycle, from pipeline to patient, by integrating the efforts of all acquired organizations. Michael Gallup's strategic direction solidifies Norstella's position as a premier global pharma intelligence solutions provider.
    Michael Gallup

    Daniel Tempesta - Chief Financial Officer

    Daniel Tempesta, the Chief Financial Officer at Norstella, oversees all financial operations and strategic financial planning. Tempesta manages the fiscal health of the organization, ensuring robust financial controls and driving profitable growth across Norstella's diverse portfolio of companies. This role involves managing budgets, forecasting financial performance, and optimizing capital allocation to support the company's mission of improving patient access. The Chief Financial Officer plays a critical part in evaluating investment opportunities and ensuring financial compliance across all business units, including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group. Daniel Tempesta's financial acumen is essential for navigating the complexities of the global pharma intelligence market and supporting the integration of advanced technologies such as real-world data and machine learning. The Chief Financial Officer's leadership ensures financial stability and supports strategic expansion initiatives.

    Elizabeth Addlesberger - Chief Revenue Officer

    Elizabeth Addlesberger, the Chief Revenue Officer at Norstella, drives the global revenue generation strategies and sales operations. Addlesberger leads the commercial teams in maximizing market penetration and expanding Norstella's client base across the life sciences sector. This position involves developing and executing sales plans that align with the company's mission to improve patient access through comprehensive pharma intelligence solutions. The Chief Revenue Officer works closely with marketing and product development to ensure commercial offerings meet evolving client needs in areas such as drug development life cycle support, real-world data, and predictive analytics. Elizabeth Addlesberger's leadership ensures that Norstella's market-leading companies, including Citeline and Evaluate, achieve their revenue targets. The Chief Revenue Officer's strategic initiatives are vital for sustained growth and reinforcing Norstella's position in the global market.

    Andrew Augustine - Chief Technology Officer

    Andrew Augustine, the Chief Technology Officer at Norstella, directs the company's technology strategy and innovation roadmap. Augustine is responsible for overseeing the development and implementation of cutting-edge technological solutions that underpin Norstella's pharma intelligence offerings. This includes managing the infrastructure for advanced technologies such as real-world data, machine learning, and predictive analytics, crucial for supporting clients from pipeline to patient. The Chief Technology Officer ensures the seamless integration of technology across Norstella's constituent organizations, enhancing data assets and advisory services. Andrew Augustine's technical leadership is pivotal in maintaining Norstella's competitive edge and enabling the delivery of must-have answers for critical strategic and commercial decision-making. The Chief Technology Officer's vision drives technological advancements that support improved patient access.

    Joel Keefe - Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation

    Joel Keefe, the Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation at Norstella, spearheads revenue growth initiatives specifically for the Mmit, Skipta, Panalgo, and Real-World Data & Evidence Generation divisions. Keefe drives commercial strategies to expand market share and client engagement within these specialized areas, focusing on delivering critical answers for strategic and commercial decision-making. This leadership role involves cultivating strong client relationships and ensuring the effective delivery of Norstella's advanced solutions, including real-world data and predictive analytics, to support the drug development life cycle. Joel Keefe's expertise is instrumental in translating complex data into actionable insights for life sciences clients. The Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation ensures these critical business units achieve their commercial objectives and contribute to Norstella's overall mission of improving patient access.
    Joel Keefe

    Kevin D'Ambrosia - Chief Revenue Officer, Heorand Rwe & Rwd & Skipta

    Kevin D'Ambrosia, the Chief Revenue Officer, Heorand Rwe & Rwd & Skipta at Norstella, leads revenue generation and commercial strategy for the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) & Real-World Data (RWD), and Skipta segments. D'Ambrosia focuses on expanding market reach and client adoption of Norstella's specialized intelligence solutions that support critical decision-making throughout the drug development life cycle. This role emphasizes driving commercial success by leveraging advanced technologies like machine learning and predictive analytics to provide unparalleled insights into patient access and market dynamics. The Chief Revenue Officer, Heorand Rwe & Rwd & Skipta works to ensure these divisions deliver exceptional value to life sciences clients, reinforcing Norstella's commitment to improving patient outcomes. Kevin D'Ambrosia's leadership is key to achieving commercial targets and enhancing Norstella's comprehensive service offerings.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Norstella Top Executives and Leadership Team

    Who leads Norstella?
    Norstella is led by Michael Gallup (Chief Executive Officer), along with executives such as Daniel Tempesta (Chief Financial Officer) and Elizabeth Addlesberger (Chief Revenue Officer).
    Who is part of Norstella’s executive team?
    The executive team of Norstella includes leaders such as Michael Gallup (Chief Executive Officer), Daniel Tempesta (Chief Financial Officer), Elizabeth Addlesberger (Chief Revenue Officer) and other senior executives.
    How many executives does Norstella have?
    Norstella has 6 executives leading key business areas.
    What roles are included in Norstella’s leadership team?
    The leadership team of Norstella includes roles such as Chief Executive Officer, Chief Financial Officer, Chief Revenue Officer, Chief Technology Officer, Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation.